bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Profit Margin (Quarterly): -573.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -573.0% |
| June 30, 2024 | -505.5% |
| March 31, 2024 | -375.8% |
| December 31, 2023 | -1.03K% |
| September 30, 2023 | -703.9% |
| June 30, 2023 | -911.3% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -107.8K% |
| June 30, 2022 | -6.59K% |
| March 31, 2022 | -6.28K% |
| December 31, 2021 | -9.65K% |
| September 30, 2021 | -21.28K% |
| June 30, 2021 | -169.0K% |
| March 31, 2021 | -23.02K% |
| December 31, 2020 | 83.27% |
| September 30, 2020 | -1.01K% |
| June 30, 2020 | -10.79% |
| March 31, 2020 | -926.7% |
| December 31, 2019 | |
| September 30, 2019 | -2.31K% |
| June 30, 2019 | -1.47K% |
| March 31, 2019 | -1.32K% |
| December 31, 2018 | -774.4% |
| September 30, 2018 | -1.26K% |
| Date | Value |
|---|---|
| June 30, 2018 | -1.86K% |
| March 31, 2018 | -721.5% |
| December 31, 2017 | -2.81K% |
| September 30, 2017 | -1.02K% |
| June 30, 2017 | -424.1% |
| March 31, 2017 | -1.01K% |
| December 31, 2016 | -4.60K% |
| September 30, 2016 | -4.96K% |
| June 30, 2016 | -3.79K% |
| March 31, 2016 | -3.75K% |
| December 31, 2015 | -3.21K% |
| September 30, 2015 | -3.24K% |
| June 30, 2015 | -1.05K% |
| March 31, 2015 | -390.7% |
| December 31, 2014 | -306.0% |
| September 30, 2014 | -267.6% |
| June 30, 2014 | -24.09% |
| March 31, 2014 | -167.5% |
| December 31, 2013 | -127.6% |
| September 30, 2013 | -95.74% |
| June 30, 2013 | -72.36% |
| March 31, 2013 | -580.7% |
| December 31, 2012 | -10.59K% |
| September 30, 2012 | -5.93K% |
| June 30, 2012 | -5.37K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-169.0K%
Minimum
Jun 2021
83.27%
Maximum
Dec 2020
-20.56K%
Average
-1.01K%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -245.9% |
| Return on Assets | -50.94% |
| Return on Invested Capital | -181.9% |
| Gross Profit Margin (Quarterly) | -11.02% |
| Operating Margin (Quarterly) | -604.1% |
| Return on Net Operating Assets | -83.21% |